Home 2013

Archives

CDC publishes updates to immunization schedules for children and adults

Vaccines are known as one of the greatest achievements in public health over the last century. And each year, it seems more vaccines are...

FDA approves Exjade to treat excess iron in patients with non-transfusion-dependent thalassemia

On Jan. 23, 2013, the U.S. Food and Drug Administration (FDA) approved the use of Exjade (deferasirox) to treat patients ages 10 years and...

Recognizing croup and stridor in children

Enhance your understanding of these two conditions.

Pediatric stroke

Learn more about this rare but dangerous condition.

Quiz Time

Which statement about breast-feeding and obesity is correct? a. Breast-feeding has no effect on the risk of obesity in children. b. Breast-feeding is associated with a...

FDA approves new combination vaccine for children

On June 14, the U.S. Food and Drug Administration (FDA) approved Menhibrix, a combination vaccine for infants and children ages 6 weeks through 18...

Effects of low to moderate alcohol intake during pregnancy examined

Preschool children of mothers who consumed low to moderate quantities of alcohol during pregnancy had no difference in test performance compared to mothers who...

Protecting children by preventing falls

Falls are the leading cause of unintentional injury to children outside hospitals and a considerable concern during hospitalization

Resurgence of pertussis in infants and children

Learn more about this dangerous disease in children.

Does periodontal disease contribute to preterm birth?

The authors discuss the answer to this question.

Unite to Fight the Flu – Influenza Season Update

There is a saying that if you’ve experienced one influenza season, you’ve experienced one influenza season. Influenza is a highly unpredictable virus, and the...

CDC releases new autism data

About 1 in 88 children in the U.S. has an autism spectrum disorder (ASD) according to a new report from the Centers for Disease...

FDA approves Surfaxin to prevent respiratory distress syndrome in premature infants.

On March 6, the U.S. Food and Drug Administration (FDA) announced the approval of Surfaxin (lucinactant) for the prevention of respiratory distress syndrome in...